カテゴリー： QYResearch, 世界

卵管癌治療薬の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Fallopian Tube Cancer Therapeutics Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18463）・商品コード：DATA909X18463
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：99
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、卵管癌治療薬の世界市場について調査・分析し、卵管癌治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（標的療法、化学療法）、用途別（病院、研究所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の卵管癌治療薬市場動向
・主要企業別マーケットシェア
・卵管癌治療薬の種類別市場規模2014-2019
（標的療法、化学療法）
・卵管癌治療薬の用途別市場規模2014-2019
（病院、研究所、その他）
・卵管癌治療薬の北米市場：主要企業・種類別/用途別市場規模
・卵管癌治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模
・卵管癌治療薬の中国市場：主要企業・種類別/用途別市場規模
・卵管癌治療薬の日本国内市場：主要企業・種類別/用途別市場規模
・卵管癌治療薬の東南アジア市場：主要企業・種類別/用途別市場規模
・卵管癌治療薬のインド市場：主要企業・種類別/用途別市場規模
・卵管癌治療薬の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（AstraZeneca Plc、Bristol-Myers Squibb Co.、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline Plc、Pfizer Inc.）
・卵管癌治療薬の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Fallopian tube cancer (PFTC), often just tubal cancer, is a malignant neoplasm that originates from the fallopian tube.At present, the global fallopian tube cancer therapeutics market lacks advanced diagnostic methods and highly effective drug delivery systems. Most of the approved drugs are small molecules that have low bioavailability challenges, despite their ability to penetrate cancer cells. To overcome such challenges, there is ongoing research on nanoparticle-based drug delivery system because of its benefits. This helps in overcoming drug resistance mechanisms in tumors and minimizes exposure time, increasing bioavailability. Such advances in nanotechnology for the effective administration of drugs, in patients who have fallopian tube cancer, will be key fallopian tube cancer therapeutics market trends that drive market growth during the forecast period.
In 2018, the global Fallopian Tube Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Fallopian Tube Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Fallopian Tube Cancer Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
AstraZeneca Plc
Bristol-Myers Squibb Co.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Pfizer Inc.
…

Market segment by Type, the product can be split into
Targeted Therapy
Chemotherapy

Market segment by Application, split into
Hospital
Research Institute
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Fallopian Tube Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Fallopian Tube Cancer Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Fallopian Tube Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Fallopian Tube Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Targeted Therapy
1.4.3 Chemotherapy
1.5 Market by Application
1.5.1 Global Fallopian Tube Cancer Therapeutics Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Research Institute
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Fallopian Tube Cancer Therapeutics Market Size
2.2 Fallopian Tube Cancer Therapeutics Growth Trends by Regions
2.2.1 Fallopian Tube Cancer Therapeutics Market Size by Regions (2019-2025)
2.2.2 Fallopian Tube Cancer Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Fallopian Tube Cancer Therapeutics Market Size by by Players
3.1.1 Global Fallopian Tube Cancer Therapeutics Revenue by by Players (2014-2019)
3.1.2 Global Fallopian Tube Cancer Therapeutics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Fallopian Tube Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Fallopian Tube Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Fallopian Tube Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Fallopian Tube Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Fallopian Tube Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Fallopian Tube Cancer Therapeutics Market Size by Application (2014-2019)

5 North America
5.1 North America Fallopian Tube Cancer Therapeutics Market Size (2014-2019)
5.2 Fallopian Tube Cancer Therapeutics Key Players in North America
5.3 North America Fallopian Tube Cancer Therapeutics Market Size by Type
5.4 North America Fallopian Tube Cancer Therapeutics Market Size by Application

6 Europe
6.1 Europe Fallopian Tube Cancer Therapeutics Market Size (2014-2019)
6.2 Fallopian Tube Cancer Therapeutics Key Players in Europe
6.3 Europe Fallopian Tube Cancer Therapeutics Market Size by Type
6.4 Europe Fallopian Tube Cancer Therapeutics Market Size by Application

7 China
7.1 China Fallopian Tube Cancer Therapeutics Market Size (2014-2019)
7.2 Fallopian Tube Cancer Therapeutics Key Players in China
7.3 China Fallopian Tube Cancer Therapeutics Market Size by Type
7.4 China Fallopian Tube Cancer Therapeutics Market Size by Application

8 Japan
8.1 Japan Fallopian Tube Cancer Therapeutics Market Size (2014-2019)
8.2 Fallopian Tube Cancer Therapeutics Key Players in Japan
8.3 Japan Fallopian Tube Cancer Therapeutics Market Size by Type
8.4 Japan Fallopian Tube Cancer Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Fallopian Tube Cancer Therapeutics Market Size (2014-2019)
9.2 Fallopian Tube Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Fallopian Tube Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Fallopian Tube Cancer Therapeutics Market Size by Application

10 India
10.1 India Fallopian Tube Cancer Therapeutics Market Size (2014-2019)
10.2 Fallopian Tube Cancer Therapeutics Key Players in India
10.3 India Fallopian Tube Cancer Therapeutics Market Size by Type
10.4 India Fallopian Tube Cancer Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Fallopian Tube Cancer Therapeutics Market Size (2014-2019)
11.2 Fallopian Tube Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Fallopian Tube Cancer Therapeutics Market Size by Type
11.4 Central & South America Fallopian Tube Cancer Therapeutics Market Size by Application

12 International Players Profiles
12.1 AstraZeneca Plc
12.1.1 AstraZeneca Plc Company Details
12.1.2 Company Description and Business Overview
12.1.3 Fallopian Tube Cancer Therapeutics Introduction
12.1.4 AstraZeneca Plc Revenue in Fallopian Tube Cancer Therapeutics Business (2014-2019))
12.1.5 AstraZeneca Plc Recent Development
12.2 Bristol-Myers Squibb Co.
12.2.1 Bristol-Myers Squibb Co. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Fallopian Tube Cancer Therapeutics Introduction
12.2.4 Bristol-Myers Squibb Co. Revenue in Fallopian Tube Cancer Therapeutics Business (2014-2019)
12.2.5 Bristol-Myers Squibb Co. Recent Development
12.3 F. Hoffmann-La Roche Ltd.
12.3.1 F. Hoffmann-La Roche Ltd. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Fallopian Tube Cancer Therapeutics Introduction
12.3.4 F. Hoffmann-La Roche Ltd. Revenue in Fallopian Tube Cancer Therapeutics Business (2014-2019)
12.3.5 F. Hoffmann-La Roche Ltd. Recent Development
12.4 GlaxoSmithKline Plc
12.4.1 GlaxoSmithKline Plc Company Details
12.4.2 Company Description and Business Overview
12.4.3 Fallopian Tube Cancer Therapeutics Introduction
12.4.4 GlaxoSmithKline Plc Revenue in Fallopian Tube Cancer Therapeutics Business (2014-2019)
12.4.5 GlaxoSmithKline Plc Recent Development
12.5 Pfizer Inc.
12.5.1 Pfizer Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Fallopian Tube Cancer Therapeutics Introduction
12.5.4 Pfizer Inc. Revenue in Fallopian Tube Cancer Therapeutics Business (2014-2019)
12.5.5 Pfizer Inc. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Fallopian Tube Cancer Therapeutics Key Market Segments
Table Key Players Fallopian Tube Cancer Therapeutics Covered
Table Global Fallopian Tube Cancer Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Targeted Therapy Figures
Table Key Players of Targeted Therapy
Figuer Chemotherapy Figures
Table Key Players of Chemotherapy
Table Global Fallopian Tube Cancer Therapeutics Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Fallopian Tube Cancer Therapeutics Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Research Institute Case Studies
Figure Other Case Studies
Figure Fallopian Tube Cancer Therapeutics Report Years Considered
Figure Global Fallopian Tube Cancer Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Fallopian Tube Cancer Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Fallopian Tube Cancer Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Fallopian Tube Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Fallopian Tube Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Fallopian Tube Cancer Therapeutics Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Fallopian Tube Cancer Therapeutics Revenue by by Players (2014-2019) (Million US$)
Table Global Fallopian Tube Cancer Therapeutics Market Share by by Players (2014-2019)
Figure Global Fallopian Tube Cancer Therapeutics Market Share by by Players in 2018
Table Global Fallopian Tube Cancer Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Fallopian Tube Cancer Therapeutics Product/Solution/Service
Table Date of Enter into Fallopian Tube Cancer Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Fallopian Tube Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Fallopian Tube Cancer Therapeutics Market Size Share by Type (2014-2019)
Figure Global Fallopian Tube Cancer Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Fallopian Tube Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Fallopian Tube Cancer Therapeutics Market Size Share by Application (2014-2019)
Figure Global Fallopian Tube Cancer Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Fallopian Tube Cancer Therapeutics Revenue Market Share by Application in 2018
Figure North America Fallopian Tube Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table North America Key Players Fallopian Tube Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table North America Key Players Fallopian Tube Cancer Therapeutics Market Share (2018-2019)
Table North America Fallopian Tube Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table North America Fallopian Tube Cancer Therapeutics Market Share by Type 2014-2019
Table North America Fallopian Tube Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table North America Fallopian Tube Cancer Therapeutics Market Share by Application 2014-2019
Figure Europe Fallopian Tube Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Fallopian Tube Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Fallopian Tube Cancer Therapeutics Market Share (2018-2019)
Table Europe Fallopian Tube Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Europe Fallopian Tube Cancer Therapeutics Market Share by Type 2014-2019
Table Europe Fallopian Tube Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Europe Fallopian Tube Cancer Therapeutics Market Share by Application 2014-2019
Figure China Fallopian Tube Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Fallopian Tube Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Fallopian Tube Cancer Therapeutics Market Share (2018-2019)
Table China Fallopian Tube Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table China Fallopian Tube Cancer Therapeutics Market Share by Type 2014-2019
Table China Fallopian Tube Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table China Fallopian Tube Cancer Therapeutics Market Share by Application 2014-2019
Figure Japan Fallopian Tube Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Fallopian Tube Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Fallopian Tube Cancer Therapeutics Market Share (2018-2019)
Table Japan Fallopian Tube Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Japan Fallopian Tube Cancer Therapeutics Market Share by Type 2014-2019
Table Japan Fallopian Tube Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Japan Fallopian Tube Cancer Therapeutics Market Share by Application 2014-2019
Figure Southeast Asia Fallopian Tube Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Fallopian Tube Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Fallopian Tube Cancer Therapeutics Market Share (2018-2019)
Table Southeast Asia Fallopian Tube Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Fallopian Tube Cancer Therapeutics Market Share by Type 2014-2019
Table Southeast Asia Fallopian Tube Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Fallopian Tube Cancer Therapeutics Market Share by Application 2014-2019
Figure India Fallopian Tube Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Fallopian Tube Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Fallopian Tube Cancer Therapeutics Market Share (2018-2019)
Table India Fallopian Tube Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table India Fallopian Tube Cancer Therapeutics Market Share by Type 2014-2019
Table India Fallopian Tube Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table India Fallopian Tube Cancer Therapeutics Market Share by Application 2014-2019
Figure Central & South America Fallopian Tube Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Fallopian Tube Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Fallopian Tube Cancer Therapeutics Market Share (2018-2019)
Table Central & South America Fallopian Tube Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Central & South America Fallopian Tube Cancer Therapeutics Market Share by Type 2014-2019
Table Central & South America Fallopian Tube Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Central & South America Fallopian Tube Cancer Therapeutics Market Share by Application 2014-2019
Table AstraZeneca Plc Company Details
Table AstraZeneca Plc Revenue in Fallopian Tube Cancer Therapeutics Business 2014-2019 (Million US$)
Figure AstraZeneca Plc Revenue Growth Rate in Fallopian Tube Cancer Therapeutics Business (2014-2019)
Table AstraZeneca Plc Recent Development
Table Bristol-Myers Squibb Co. Company Details
Table Bristol-Myers Squibb Co. Revenue in Fallopian Tube Cancer Therapeutics Business 2014-2019 (Million US$)
Figure Bristol-Myers Squibb Co. Revenue Growth Rate in Fallopian Tube Cancer Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Co. Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Revenue in Fallopian Tube Cancer Therapeutics Business 2014-2019 (Million US$)
Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Fallopian Tube Cancer Therapeutics Business (2014-2019)
Table F. Hoffmann-La Roche Ltd. Recent Development
Table GlaxoSmithKline Plc Company Details
Table GlaxoSmithKline Plc Revenue in Fallopian Tube Cancer Therapeutics Business 2014-2019 (Million US$)
Figure GlaxoSmithKline Plc Revenue Growth Rate in Fallopian Tube Cancer Therapeutics Business (2014-2019)
Table GlaxoSmithKline Plc Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Revenue in Fallopian Tube Cancer Therapeutics Business 2014-2019 (Million US$)
Figure Pfizer Inc. Revenue Growth Rate in Fallopian Tube Cancer Therapeutics Business (2014-2019)
Table Pfizer Inc. Recent Development
Table Global Fallopian Tube Cancer Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Fallopian Tube Cancer Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Fallopian Tube Cancer Therapeutics Market Size Share by Regions in 2025
Figure North America Fallopian Tube Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Fallopian Tube Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Fallopian Tube Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Fallopian Tube Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Fallopian Tube Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Fallopian Tube Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Fallopian Tube Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Fallopian Tube Cancer Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Fallopian Tube Cancer Therapeutics Market Size by Product (2019-2025)
Figure Global Fallopian Tube Cancer Therapeutics Market Size by Product in 2025
Table Global Fallopian Tube Cancer Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Fallopian Tube Cancer Therapeutics Market Size by Application (2019-2025)
Figure Global Fallopian Tube Cancer Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

AstraZeneca Plc、Bristol-Myers Squibb Co.、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline Plc、Pfizer Inc.

★調査レポート[卵管癌治療薬の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18463)販売に関する免責事項を必ずご確認ください。
★調査レポート[卵管癌治療薬の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 咽頭がん治療薬の世界市場：規模・現状・予測2019-2025
    DATA909X19030 / QYResearch / 2019年11月25日 / ※当調査レポートでは、咽頭がん治療薬の世界市場について調査・分析し、咽頭がん治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（手術、放射線療法、化学療法）、用途別（中咽頭がん、喉頭がん）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の咽頭がん治療薬市場動向 ・主要企業別マーケットシェア ・咽頭がん治療薬の種類別市場規模2014-2019 （手術、放射線療法、化学療法） ・咽頭がん治療薬の用途別市場規模2014-2019 （中咽頭がん、喉頭がん） ・咽頭がん治療薬の北米市場：主要企業・種類別/用途別市場規模 ・咽頭がん治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Laryngeal cancer are mostly squamous cell carcinomas, reflecting their origin from the skin of the larynx.Oropharyngeal cancer is a disease in which cancer form in the tissues of the throat (oropharynx).There is an increase in the prevalence of throat cancer across the world despite advances in the research of therapeutics and the healthcare infrastructure. Throat cancer is one of the most prevalent cancer types in Europe, Asia, and North America. Additionally, the mortality rate of this indication has increased over the past few years in the US. This has resulted in a substantial unmet market that is attracting pharmaceutical vendors...
  • 胆嚢癌療法の世界市場：規模・現状・予測2019-2025
    DATA909X18497 / QYResearch / 2019年11月25日 / ※当調査レポートでは、胆嚢癌療法の世界市場について調査・分析し、胆嚢癌療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（併用療法、単剤療法）、用途別（病院、医学研究所、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の胆嚢癌療法市場動向 ・主要企業別マーケットシェア ・胆嚢癌療法の種類別市場規模2014-2019 （併用療法、単剤療法） ・胆嚢癌療法の用途別市場規模2014-2019 （病院、医学研究所、クリニック、その他） ・胆嚢癌療法の北米市場：主要企業・種類別/用途別市場規模 ・胆嚢癌療法のヨーロッパ市場：主要企業・種類別/用途別市場規模...Rising incidence of cholelithiasis, chronic inflammation of the gallbladder, and gallbladder polyps are contributing to the prevalence of gallbladder cancer. This has resulted in a rise in demand for therapeutics for treating the condition.Surgery is considered the primary treatment approach for gallbladder cancer, which involves the complete removal of the organ. However, the second line of treatment involves the use of radiation therapy along with chemotherapeutics. The rising availability of financial assistance programs is further helping patients in availing these high-cost treatments. With the increasing occurrence of these risk factors, the need for gallbladder cancer therapeutics will subsequently increase over...

    • ◆H&Iグローバルリサーチのお客様（例）◆